Nanosuspension Technology for Delivery of Poorly Soluble Drugs and Its Applications: A Review
DOI:
https://doi.org/10.37285/ijpsn.2020.13.4.1Abstract
Now a days, many drug candidates are water insoluble hence they show a limited drug release and poor bioavailability. It is difficult to formulate these drugs by conventional dosage form. Nanosuspension technology is a promising approach to solve the problems of poorly soluble and less bioavailable drugs. Nanosuspension is a very finely colloidal, biphasic, and uniformly dispersed solid drug particles in a suitable aqueous vehicle, having a particle size below 1 μm stabilized by suitable surface active agents and polymers. Nanosuspensions are prepared by various suitable techniques for drug delivery applications. Due to reduced particle size at the nano scale, surface area, saturation solubility, dissolution velocity and bioavailability of BCS class II and class IV drugs are increased sufficiently. Nanosuspension is suitable to administration via various routes such as oral, intravenous, topical, pulmonary and ocular delivery systems. Nanosuspension can be also used for targeting purpose in various diseases such as cancer, HIV and production of sustained and extended release products by choosing suitable polymers. Production and manufacturing are not complicated, easy to scale up. Top down and bottom technologies are used for the preparation of nanosuspensions. It includes methods such as high-pressure homogenization, by milling media method, precipitation method, probe sonication, dry-co-grinding, supercritical fluid method, and lipid emulsion method. Formulation consists of stabilizers, surfactant, and solvents. Nanosuspension can be stored in the form of dry powder using spray drying, freeze drying techniques. This review describes the advantages, various methods of preparation, formulation consideration and characterization of nanosuspension.
Downloads
Metrics
Keywords:
Nanosuspension, Solubility, Techniques, Bioavailability enhancement, Applications.
Downloads
Published
How to Cite
Issue
Section
References
Aher SS, Malsane AT, and Saudagar RB (2019). Nano-suspension: an overview. Int J Curr Pharm Res, 9: 1-10.
Ahire E, Thakkar S, Darshanwad M, and Misra M (2018). Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications. Acta Pharm Sin B, 8: 733-755.
Alshweiat A, Katona G, Csoka I, and Ambrus R (2018). Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation. Eur J Pharm Sci, 122: 94-104.
Arunkumar N, Deecaraman M, and Rani C (2009). Nanosuspension technology and its applications in drug delivery. Asian J Pharm, 3: 168-173.
Athul PV (2013). Preparation and characterization of simvastatin nanosuspension by homogenization method. Int J Pharm Tech Res, 5: 193-197.
Banavath H, Sivarama RK, and Ansari MT (2010). Nano-suspension: An attempt to Enhance Bioavailability of Poorly Soluble Drugs. Int J Pharm Sci Res, 1: 1-11.
Bhakay A, Rahman M, Dave RN, and Bilgili E (2018). Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites : Formulation – Processing Aspects and Challenges. Pharmaceutics, 10: 1-62.
Bhalekar MR, Upadhaya PG, Reddy S, and Kshirsagar SJ, (2014). Formulation and evaluation of acyclovir nanosuspension for enhancement of oral bio-availability. Asian J Pharm, 8: 110-118.
Bhowmik D, Harishl G, Duraivel S, et al (2013). Nano-suspension- A novel approach in drug delivery system. Pharma Innovation, 1: 50-63.
Chattopadhyay P, Shekunov BY, Yim D, Cipolla D, Boyd B, Farr S (2007). Production of solid lipid nano-particle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev, 59: 444-453.
Chaudhari SP, Kamble SC, Mahajan RA, et al (2013). Nanosuspension -A Novel Approaches in Drug Delivery System. IJPRR, 2(12): 30-39.
Chaurasia T, Singh D, and Shrivastava D (2012). A review on nanosuspensions promising drug delivery strategy. Current Pharma Research, 3: 764-776.
Chingunpitak J, Puttipipatkhachorn S, Chavalitshe-winkoon-petmitr P, Tozuka Y, Moribe K, and Yamamoto K (2008). Formation, Physical Stability and In Vitro Antimalarial Activity of Dihydroartemisin in Nanosuspensions Obtained by Co-grinding Method. Drug Dev Ind Pharm, 34: 314-322.
Chingunpituk J (2007). Nanosuspension Technology for Drug Delivery. Walailak J Sci& Tech, 4: 139-153.
Deoli M (2012). Nanosuspension Technology for Solubilizing Poorly Soluble drugs. Int J Drug Dev & Res, 4: 40-49.
Eerdenbrugh BV, Mooter GVD, and Augustijns P (2008). Top-down production of drug nanocrystals: Nano-suspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 364: 64-75.
El-feky G, Zayed G, and Farrag ARH (2013). Optimization of an ocular nanosuspension formulation for acyclovir using factorial design. Int J Pharm Pharm Sci, 5: 213-219.
Ganesh B, Ankita R, and Preeti K (2013). A New Emerging Technique for Biovailability Enhancement. Am J Adv Drug Deliv, 1: 197-211.
Gao Y, Li Z, Sun M, et al (2011). Preparation and characterization of intravenously injectable curcumin nano-suspension. Drug delivery, 18: 131-142.
Geetha G, Poojitha U, and Khan KAA (2014). Various Techniques for Preparation of Nano-suspension- A Review. IJPRR, 3: 30-37.
Godge G, Labade S and Misal A (2015). Oral Bioavailability Improvement Using Solid Dispersion Techniques: A Review. Int J Life Sci Rev, 1: 243-252.
Godge G, Hiremath S (2012). Colonic delivery of film coated meloxicam tablets using natural polysaccharide polymer mixture. Int Curr Pharm J, 1: 264-271.
Godge GR and Labade SP (2015). Preparation of Solid Dispersion of Poorly Water Soluble Drug Formulation and Consideration. Int J Pharm Sci Res, 6: 897-903.
Godge GR, Misal AV, and Pawar PY (2015). Formulation and Evaluation of Mouth Dissolving Tablet with Taste Masking Resin. IntJ Life Sci Rev, 1: 253-263.
Godge GR and Hiremath SN (2013). Colon Targeted Drug Delivery System: A Review. Int. J. Pharm. Drug Ana., 2: 35-48.
Godge GR, Hiremath SN (2014). Development and Evaluation of Colon Targeted Drug Delivery System by Using Natural Polysaccharides/Polymers. Dhaka Univ. J. Pharm. Sci, 13: 105-113.
Guo C, Chen Y, and Zhu J (2018). Preparation, optimization of intravenous ZL-004 nanosuspensions by the precipitation method, effect of particle size on in vivo pharmacokinetic and tissue distribution. J Drug Deliv Sci Technol, 1: 1-40.
Hetal T, Bindesh P, and Sneha T (2010). A Review On Techniques For Oral Bioavailability Enhancement of Drugs. IntJ Pharm SciRev Res, 4: 203-223.
Hiremath S and Godge G (2012). Preparation and in vitro Evaluation of Inclusion Complexes of Nelfinavir with Chemically Modified β-cyclodextrins. Dhaka Univ. J. Pharm. Sci, 11: 107-116.
Hiremath S, Godge G, Sonawale B and Shirsath R (2015). Pharmaceutical Advances InCyclodextrin Inclusion Complexes for Improved Bioavailability of Poorly-Soluble Drugs. Int J Pharm Sci Nanotech, 8: 2894-2905.
Hiremath SN, Godge GR, Kharia AA, and Vaidya VR (2010). Studies On The Preparation, Characterization And Solubility Of Β-Cyclodextrin-Nelfinavir Inclusion Complexes. JPRHC, 2: 279-284.
Hiremath SN, Kharia AA, and Godge GR (2010). Formulation Strategies for Low Absorption Window Antihypertensive Agents. Res J Pharm Technol, 3: 83-91.
Hiremath SN and Godge GR (2011). Recent Advances In Pharmaceutical Approaches to Colon Specific Drug Delivery. Pharm Tech, 5: 1-8.
Hitanga J, Sharma N, Chopra H, and Kumar S(2015). Nanoprecipitation technique employed for the development of nano-suspension: A review. WJPPS, 4: 2127-2136.
Honary S and Zahir F (2013). Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2). Trop J Pharm Res. 12: 265-273.
Ige PP, Baria RK, and Gattani SG (2013). Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Colloids Surf B Biointerfaces 108: 366-377.
Iqubal MK, Hamdard J, and Shukla VK (2014). Review Article Microemulsions: Current Trends in Novel Drug Delivery System. J Pharm Chem Biol Sci, 1: 39-51.
Jacobs C and Müller RH (2002). Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration. Pharm Res. 19:189-190.
Kalvakuntla S, Deshpande M, and Attari Z (2016). Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process. Adv Pharm Bull, 6: 83-90.
Karakucuk A, Teksin ZS, Eroglu H, and Celebi N (2019). Evaluation of improved oral bioavailability of ritonavir nano-suspension. Eur J Pharm Sci, 131: 153-158.
Kassas RA, Bansal M, and Shaw J (2017). Nanosizing techniques for improving bioavailability of drugs. J Control release 2: 1-38.
Kassem MA, Rahman AAA, Ghorab MM, Ahmed MB, and Khalil RM (2007). Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm, 340: 126-133.
Kavitha VB, Neethu CS, Dineshkumar B, Krishnakumar K, and John A (2014). Nanosuspension Formulation: An Improved Drug Delivery System. Nanoscience and Nanotechnology 4:1-5.
Kayser O and Lemke A (2005). The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems. Curr Pharm Biotechnol, 6: 3-5.
Kayser O, Olbrich C, and Yardley V (2003). Formulation of amphotericin B as nanosuspension for oral administration. Int J Pharm, 254: 73-75.
Kayser O (2000). Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages. Int J Pharm, 96: 253-256.
Kharia AA, Hiremath SN, Omray LK, Yadav R, and Godge GR (2011). Gastro-retentive Drug Delivery System. Indian Drugs, 48: 7-15.
Kilor VA and Birade PA (2018). Formulation and evaluation of glimepiride nanosuspension using simple high shear homogenizer at lab scale. Ijppr. Human, 14: 20-29.
Kumari K and Shrinivasa Rao (2017). Nano-suspension: A Review. Int J Pharm, 7: 77-89.
Lakshmi P and Kumar GA (2010). Nano Suspension Technology: A Review. Int J pharm Sci, 2: 35-40.
Li X (2011). Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery. Int J Nanomed 6: 1497-1507.
Liu T and Mu RH (2015). Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nano-suspension. Expert Opin Drug Deliv, 12: 1-14.
Liu Y, Xie P, Zhang D, and Zhang Q (2012). A mini review of nanosuspension development. J Drug Target, 20: 209-223.
Liversidge EM, and Liversidge GG (2011). Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev, 63: 427-440.
Malakar J, Basu A, and Ghosh A (2012). Nanosuspension: A Nano-Heterogeneous Carrier for Drug Delivery System. Int J Pharm Biol Sci Arch, 3: 4-13.
Mane AN, Gilda SS, GhadgeAA, and Bhosekar NR (2014). Nanosuspension – A Novel Carrier ForLipidic Drug Transfer. Sch Acad J Pharm, 3: 82-88.
Mathew M, Krishnakumar K, Dineshkumar B, and Nair SK (2017). Antibiotics Nanosuspension: A Review. J Drug Del Ther, 7: 128-131.
Medarevic D, Djuris J, Ibric S, Mitric M, and Kachrimanis K (2018). Optimization of formulation and process parameters for the production of carvedilolnanosuspension by wet media milling. Int J Pharm 22: 1-54.
Mujtaba MA, Alotaibi NM, and Eltaib L (2019). Fabrication of ciprofloxacin nanocrystals by probe sonication method for enhancement of dissolution rate. Res J Pharm Biol Chem Sci, 10: 891-898.
Muller RH, Jacob C, and Kayser O (2001). Nanosuspension as particulate drug formulations in therapy rational for development and what we can expect for the future. Adv Drug Deliv Rev, 47: 3-19.
Muller RH, and Krause KP (2001). Production and characterisation of highly concentrated nanosus-pension by high-pressure homogenisation. Int J Pharm, 214: 21-24.
Nair A, Khunt D, and Misra M (2018). Application of quality by design for optimization of spray drying process used in drying of Risperidonenano-suspension. Powder Technol, 1-17.
Nayak BS and Roy H (2018). Nanosuspension: Bioavailability enhancing novel approach. Int J Pharm Biol Sci, 8: 540-554.
Niwa T, Miura S, and Danjo K (2011). Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies – Development of particle design method. Int J Pharm, 405: 218-227.
Parekh KK, Paun JS, and Soniwala MM (2017). Formulation and evaluation of nanosuspension to improve solubility and dissolution of diacerein. IJPSR, 8: 1643-1653.
Parmar S, Shah DP and Yadav J (2016). Nano-suspension: A Promising Drug Delivery System for Poorly Water Soluble drug and Enhanced Bioavailability. Ijppr Human, 6: 109-125.
Patel HM, Patel BB, and Shah CN (2016). Nano-suspension: A novel approch to enhance solubility of poorly water-soluble drugs - A review. Int J Adv Pharm, 5: 21-29.
Patel HM, Patel UB, Shah C, and Akbari B (2018). Formulation and Development of Nanosuspension as an Alternative Approach for Solubility and Dissolution Enhancement of Aceclofenac. Int J Adv Pharm 7: 33-47.
Patel PB, Shastri DH, Shelat PK, and Shukla AK (2010). Ophthalmic Drug Delivery System: Challenges and Approaches. Sys Rev Pharm, 1: 113-120.
Patel VR and Agrawal YK (2011). Nano-suspension: An approach to enhance solubility of drugs. J Adv Pharm Tech Res, 2: 81-88.
Patravale VB, Date AA, and Kulkarni RM (2004). Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56: 827-840.
Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, and Ehlers S (2000). Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine. J Antimicrob Chemother, 45: 77-83.
Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, and Puglisi G (2002). Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci, 16: 53-61.
Pu X, Sun J, Li M, and He Z (2009). Formulation of Nano-suspensions as a New Approach for the Delivery of Poorly Soluble Drugs. Current Nanoscience. 5(4): 417-427.
Rabinow BE (2004). Nanosuspensions in Drug Delivery. Drug discovery, 3: 785-796.
Rao GCS, Kumar MS, Mathivanan N, and Rao MEB (2004). Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems. Pharmazie. 1: 5-9.
Raskar MA, Godge GR, Chitale AB and Giri PD (2015). Validated simultaneous spectrophotometric estimation of telmisartan, hydrochlorthiazide and amlodipine besylate in combined tablet dosage form. Der Pharmacia Lettre, 7: 120-124.
Sanap D, Garje M, and Godge G (2019). Probiotics, their Health Benefits and Applications for Development of Human Health: A Review. J Drug Del Ther 9: 631-640
Shah DP, Patel B, and Shah C (2015). Nanosuspension Technology: An Innovative Slant for Drug Delivery System and Permeability Enhancer for Poorly Water Soluble Drugs. J Drug Del Ther, 5: 10-23.
Shegokar R (2014). Nanosuspensions: A new approach for organ and cellular targeting. Infectious Diseases 43: 1-26.
Shekhawat P and Pokharkar V (2019). Risk assessment and QbD based optimization of an Eprosartanmesylate nano-suspension: In-vitro characterization, PAMPA and in-vivo assessment. Int J Pharm. 567: 1-18.
Shid RL, Dhole SN, et al (2015) Formulation and Evaluation of Nanosuspension of Simvastatin. Int J Pharm Sci Nanotech, 8: 2858-2873.
Shid RL, Dhole SN, Kulkarni N, and Shid SL (2013). Nanosuspension: A Review. Int J Pharm Sci Rev Res, 22: 98-106.
Singh MK, Pooja D, and Ravuri HG (2017). Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiological properties and low oral bioavailability. Phytomedicine, 1-29.
Sinha B, Mullar RH, and Moschwitzer JP (2012). Bottom-up approaches for preparing drug nanocrystals, 1-58.
Sunder S, and Nair R (2016). Methods of Nanonization of Drugs for Enhancing their Dissolution. Euro J Adv Engg Tech, 3: 101-110.
Tashan E, Karakucuk A, and Celebi N (2019). Optimization and in vitro evaluation of ziprasidone nanosuspensions produced by a top-down approach. J Drug Deliv Sci Technol, 52: 37-45.
Thassu D, Deleer M, and Pathak Y (2007). Nanoparticulate Drug Delivery System: an Overview. Nanoparticulate Drug Delivery System 8: 21-52.
Thattil JG, Kumar KK, and Kumar BD (2018). Nanosuspension technology in pharmaceuticals. J Bio Innov 7: 660-677.
Vaidya VR, Karodi RS, Mohite MT, Hiremath SN, and Godge GR (2010). Formulation Optimization Of MucoadhesiveBuccal Tablets Of Carvedilol Using 32 Full Factorial Design. Deccan J. Pharmaceutics and Cosmetology, 1: 7-20.
Velmula M, Pavuluri P, Rajashekar S, and Rao VUM (2015). Nanosuspension technology for poorly soluble drugs - a review. WJPPS, 4: 1612-1625.
Venkatesh T, Reddy AK, Maheswari JU, and Dalith MD (2011). Nanosuspensions: Ideal Approach for the Drug Delivery of Poorly Water Soluble Drugs. Der Pharmacia Lettre, 3: 203-213.
Wang H, Xiao Y, and Wang H (2019). Development of daidzein nano suspensions: Preparation, characteri-zation, in vitro evaluation, and pharmacokinetic analysis. Int J Pharm, 566: 67-76.
Wang L, Du J, Zhou Y, and Wang Y (2016). Safety of nanosuspensions in drug delivery. Nanomedicine Nanotechnology, Biol Med, 1-64.
Wang L, Tian S, and Wang Y (2015). Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. Int J Pharm, 1-49.
Wang X, Liu Y, Shen C, Shen B, Zhong R, and Yuan H (2019). Effect of particle size on in vitro and in vivo behavior of astilbinnanosuspensions. J Drug DelivSci Technol. 52: 778-783.
Wang Y, Wang C, and Zhao J (2017). A cost- effective method to prepare curcuminnanosuspension with enhanced oral bioavailability. J Colloid Interface Sci, 485: 91-98.
Xia D, Quan P, and Piao H (2010). Preparation of stable nitrendipine nanosuspension using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci, 40: 325-334.
Yadav GV and Singh SR (2012). Nanosuspension: A promising drug delivery system. Pharmacophore 3: 217-243.
Yadav M, Dhole S, and Chavan P (2014). Nanosuspension: A novel technique in drug delivery system. WJPPS 3: 410-433.
Yadollahi R, Vasilev K, and Simovic S (2015). Nanosuspension Technologies for Delivery of Poorly Soluble drugs. J Nanomater, 1-13.
Yang H, Teng F, and Wang P (2014) Investigation of a nanosuspension stabilized by Soluplus 1 to improve bioavailability. Int J Pharm, 477: 88-95.
